• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性鼻-鼻窦炎患者的哮喘发病模式和患者结局。

Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population.

机构信息

Feinberg School of Medicine, Northwestern University, Chicago, IL.

Department of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL.

出版信息

Int Forum Allergy Rhinol. 2018 Apr;8(4):495-503. doi: 10.1002/alr.22064. Epub 2018 Jan 5.

DOI:10.1002/alr.22064
PMID:29316300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5987551/
Abstract

BACKGROUND

Chronic rhinosinusitis (CRS) is strongly associated with comorbid asthma. This study compares early-onset and late-onset asthma in a CRS population using patient-reported and clinical characteristics.

METHODS

At enrollment into a clinical registry, CRS patients completed the 22-item Sino-Nasal Outcome Test (SNOT-22), Asthma Control Test (ACT), mini-Asthma Quality of Life Questionnaire (miniAQLQ), the 29-item Patient-Reported Outcomes Measurement Information System (PROMIS-29), and medication use questionnaires. Patients also reported comorbid asthma and age at first asthma diagnosis. Early-onset (<18 years) and late-onset (>18 years) asthma groups were defined. Analysis of variance (ANOVA), chi-square, and Kruskal-Wallis tests were used to compare patient responses.

RESULTS

A total of 199 non-asthmatic (56.1%), 71 early-onset asthmatic (20.0%), and 85 late-onset asthmatic (23.9%) CRS patients completed the survey. Body mass index (BMI) was significantly higher in late-onset asthmatic (p = 0.046) while age, gender, race, and smoking history did not differ with time of asthma onset. SNOT-22, ACT, and miniAQLQ were not different between asthma groups, but late-onset asthmatics had significantly lower physical function than non-asthmatics (p = 0.008). Compared to non-asthmatics, late-onset asthmatics showed increased rates of nasal polyps (p < 0.001), higher Lund-Mackay scores (p = 0.005), and had received more oral steroid courses (p < 0.001) and endoscopic surgeries (p = 0.008) for CRS management. Late-onset asthmatics compared to early-onset asthmatics showed increased nasal polyposis (p = 0.011) and oral steroid courses for CRS (p = 0.003).

CONCLUSION

While CRS-specific and asthma-specific patient-reported outcome measures (PROMs) were not significantly different among groups, CRS patients with late-onset asthma had poorer physical function, more frequent nasal polyposis, and required increased treatment for CRS. Late-onset asthma may predict more severe disease in CRS.

摘要

背景

慢性鼻-鼻窦炎(CRS)与合并哮喘密切相关。本研究通过患者报告和临床特征比较 CRS 人群中的早发性和迟发性哮喘。

方法

在临床登记处入组时,CRS 患者完成了 22 项鼻-鼻窦结局测试(SNOT-22)、哮喘控制测试(ACT)、迷你哮喘生活质量问卷(miniAQLQ)、29 项患者报告结局测量信息系统(PROMIS-29)和用药问卷。患者还报告了合并哮喘和首次哮喘诊断的年龄。定义早发性(<18 岁)和迟发性(>18 岁)哮喘组。采用方差分析(ANOVA)、卡方检验和 Kruskal-Wallis 检验比较患者的反应。

结果

共完成了 199 例非哮喘(56.1%)、71 例早发性哮喘(20.0%)和 85 例迟发性哮喘(23.9%)CRS 患者的调查。迟发性哮喘患者的体重指数(BMI)显著高于早发性哮喘(p = 0.046),而年龄、性别、种族和吸烟史与哮喘发病时间无差异。哮喘组间 SNOT-22、ACT 和 miniAQLQ 无差异,但迟发性哮喘患者的身体功能明显低于非哮喘患者(p = 0.008)。与非哮喘患者相比,迟发性哮喘患者鼻息肉发生率更高(p<0.001),Lund-Mackay 评分更高(p=0.005),CRS 管理中接受的口服类固醇疗程更多(p<0.001)和内镜手术更多(p=0.008)。与早发性哮喘患者相比,迟发性哮喘患者鼻息肉(p=0.011)和 CRS 的口服类固醇疗程(p=0.003)更多。

结论

虽然各组间 CRS 特异性和哮喘特异性患者报告结局测量(PROMs)无显著差异,但迟发性哮喘的 CRS 患者身体功能较差,鼻息肉更频繁,需要更多的 CRS 治疗。迟发性哮喘可能预示着 CRS 更严重的疾病。

相似文献

1
Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population.慢性鼻-鼻窦炎患者的哮喘发病模式和患者结局。
Int Forum Allergy Rhinol. 2018 Apr;8(4):495-503. doi: 10.1002/alr.22064. Epub 2018 Jan 5.
2
Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis.慢性鼻-鼻窦炎患者鼻窦手术后的哮喘生活质量与控制情况
Allergy. 2017 Mar;72(3):483-491. doi: 10.1111/all.13048. Epub 2016 Sep 30.
3
SNOT-22-based clusters in chronic rhinosinusitis without nasal polyposis exhibit distinct endotypic and prognostic differences.SNOT-22 基聚类在非鼻息肉型慢性鼻-鼻窦炎中的表现出不同的表型和预后差异。
Int Forum Allergy Rhinol. 2018 Jul;8(7):797-805. doi: 10.1002/alr.22101. Epub 2018 Feb 13.
4
Gender-specific differences in chronic rhinosinusitis patients electing endoscopic sinus surgery.慢性鼻-鼻窦炎患者行内镜鼻窦手术的性别差异。
Int Forum Allergy Rhinol. 2016 Mar;6(3):278-86. doi: 10.1002/alr.21667. Epub 2015 Nov 17.
5
Clustering of chronic rhinosinusitis symptomatology reveals novel associations with objective clinical and demographic characteristics.慢性鼻-鼻窦炎症状聚类分析揭示了与客观临床及人口统计学特征的新关联。
Am J Rhinol Allergy. 2015 Mar-Apr;29(2):100-5. doi: 10.2500/ajra.2015.29.4140.
6
Twenty-two-item Sino-Nasal Outcome Test in a control population: a cross-sectional study and systematic review.22 项中文版鼻-鼻窦结局测试在健康人群中的应用:一项横断面研究和系统评价。
Int Forum Allergy Rhinol. 2016 Mar;6(3):271-7. doi: 10.1002/alr.21668. Epub 2015 Nov 26.
7
The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights.欧洲慢性鼻窦炎患者的SNOT-22因子结构:新的临床见解。
Eur Arch Otorhinolaryngol. 2019 May;276(5):1355-1365. doi: 10.1007/s00405-019-05320-z. Epub 2019 Feb 9.
8
Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset.年龄相关性慢性鼻-鼻窦炎和鼻息肉的流行情况及其与哮喘发病的关系。
Ann Allergy Asthma Immunol. 2018 Apr;120(4):389-394. doi: 10.1016/j.anai.2018.02.005. Epub 2018 Feb 9.
9
Atopy in chronic rhinosinusitis: impact on quality of life outcomes.变应性在慢性鼻-鼻窦炎中的作用:对生活质量结局的影响。
Int Forum Allergy Rhinol. 2019 May;9(5):501-507. doi: 10.1002/alr.22272. Epub 2019 Jan 3.
10
Combined measurements of fractional exhaled nitric oxide and nasal nitric oxide levels for assessing upper airway diseases in asthmatic patients.联合测量呼出气一氧化氮分数和鼻一氧化氮水平以评估哮喘患者的上气道疾病
J Asthma. 2018 Mar;55(3):300-309. doi: 10.1080/02770903.2017.1332203. Epub 2017 Jun 21.

引用本文的文献

1
Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a analysis from the ANANKE study.在伴有和不伴有鼻息肉的慢性鼻-鼻窦炎的重度嗜酸性粒细胞性哮喘患者中,贝那利珠单抗疗效的持久性:来自ANANKE研究的分析
Front Allergy. 2025 Mar 20;6:1501196. doi: 10.3389/falgy.2025.1501196. eCollection 2025.
2
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational Study.重症嗜酸性粒细胞性哮喘和慢性鼻-鼻窦炎伴鼻息肉患者使用贝那利珠单抗治疗2年后的鼻窦结局:一项“真实世界”观察性研究。
J Pers Med. 2024 Sep 23;14(9):1014. doi: 10.3390/jpm14091014.
3

本文引用的文献

1
Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis.使用患者报告结局测量评估慢性鼻-鼻窦炎的反应性指标。
Int Forum Allergy Rhinol. 2017 Feb;7(2):128-134. doi: 10.1002/alr.21866. Epub 2016 Nov 7.
2
Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis.慢性鼻-鼻窦炎患者鼻窦手术后的哮喘生活质量与控制情况
Allergy. 2017 Mar;72(3):483-491. doi: 10.1111/all.13048. Epub 2016 Sep 30.
3
Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample.
The role of radiological imaging in the management of severe and difficult-to-treat asthma.
放射影像学在重度及难治性哮喘管理中的作用
Breathe (Sheff). 2024 Jul 16;20(2):240033. doi: 10.1183/20734735.0033-2024. eCollection 2024 Jun.
4
The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review.生物制剂对联合气道疾病患者肺功能和生活质量的影响:一项系统评价。
J Allergy Clin Immunol Glob. 2023 Sep 28;3(1):100174. doi: 10.1016/j.jacig.2023.100174. eCollection 2024 Feb.
5
Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice.嗜酸粒细胞性气道疾病:从病理生理机制到临床实践。
Int J Mol Sci. 2023 Apr 14;24(8):7254. doi: 10.3390/ijms24087254.
6
Canadian multidisciplinary expert consensus on the use of biologics in upper airways: a Delphi study.加拿大多学科专家共识:生物制剂在上呼吸道疾病中的应用:德尔菲研究。
J Otolaryngol Head Neck Surg. 2023 Apr 24;52(1):30. doi: 10.1186/s40463-023-00626-9.
7
B Lineage Cells and IgE in Allergic Rhinitis and CRSwNP and the Role of Omalizumab Treatment.B 谱系细胞和 IgE 在变应性鼻炎和 CRSwNP 中的作用及奥马珠单抗治疗的作用。
Am J Rhinol Allergy. 2023 Mar;37(2):182-192. doi: 10.1177/19458924221147770.
8
Dupilumab (Dupixent) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany.度普利尤单抗(度必特)治疗控制不佳的重度慢性鼻-鼻窦炎伴鼻息肉有效:德国一所大学附属医院单中心、回顾性、单臂纵向研究的真实数据。
Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1741-1755. doi: 10.1007/s00405-022-07679-y. Epub 2022 Oct 15.
9
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study.美泊利珠单抗改善重度哮喘患者慢性鼻-鼻窦炎伴鼻息肉的预后:一项多中心真实世界研究
J Pers Med. 2022 Aug 10;12(8):1304. doi: 10.3390/jpm12081304.
10
Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP.在伴有 CRSwNP 的轻中度支气管哮喘患者中,度普利尤单抗的真实疗效。
BMC Pulm Med. 2022 Jun 28;22(1):258. doi: 10.1186/s12890-022-02046-3.
基于人群样本的鼻及鼻窦症状与慢性鼻-鼻窦炎
Allergy. 2017 Feb;72(2):274-281. doi: 10.1111/all.13042. Epub 2016 Sep 19.
4
International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.国际过敏与鼻科学学会共识声明:鼻窦炎。
Int Forum Allergy Rhinol. 2016 Feb;6 Suppl 1:S22-209. doi: 10.1002/alr.21695.
5
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort.欧洲 U-BIOPRED 成人严重哮喘队列的临床和炎症特征。
Eur Respir J. 2015 Nov;46(5):1308-21. doi: 10.1183/13993003.00779-2015. Epub 2015 Sep 10.
6
Five-year risk of incident disease following a diagnosis of chronic rhinosinusitis.慢性鼻窦炎诊断后疾病发生的五年风险。
Allergy. 2015 Dec;70(12):1613-21. doi: 10.1111/all.12759. Epub 2015 Sep 25.
7
Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Retrospective analysis using the UK clinical practice research data.接受鼻内镜鼻窦手术的时间会影响慢性鼻窦炎的治疗效果吗?基于英国临床实践研究数据的回顾性分析。
Rhinology. 2015 Mar;53(1):18-24. doi: 10.4193/Rhino14.077.
8
Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis.接受内镜鼻窦手术的时间会影响慢性鼻-鼻窦炎的治疗效果吗?鼻息肉和慢性鼻-鼻窦炎手术全国比较性审计的前瞻性研究结果。
Rhinology. 2015 Mar;53(1):10-7. doi: 10.4193/Rhino13.217.
9
Early versus delayed endoscopic sinus surgery in patients with chronic rhinosinusitis: impact on health care utilization.慢性鼻窦炎患者早期与延迟内镜鼻窦手术:对医疗资源利用的影响
Otolaryngol Head Neck Surg. 2015 Mar;152(3):546-52. doi: 10.1177/0194599814565606. Epub 2015 Jan 8.
10
Pathogenesis of nasal polyposis.鼻息肉病的发病机制。
Clin Exp Allergy. 2015 Feb;45(2):328-46. doi: 10.1111/cea.12472.